What Leem does

Leem (Les Entreprises du Médicament) is the designated French professional trade organization (syndicat professionnel, RCS 784 668 543) representing pharmaceutical companies operating in France. Founded with branch-level industry observatory activity dating to 1994 and headquartered at 58 Boulevard Gouvion-Saint-Cyr, Paris, Leem serves as the single sectoral voice for its member companies in regulatory, pricing (PLFSS/CEPS), reimbursement, ethics, employment, and training matters. Its primary constituency is French pharmaceutical company members paying recurring membership dues, with secondary stakeholder relationships across French ministries, Parliament, regulators (CEPS, HAS, CNIL), patient associations, healthcare professionals, and job seekers.

Leem operates a platform-plus-modules architecture centered on leem.org, with an Espace Adhérents members-only portal, Le Lab forward-looking analysis hub, Codeem ethics and deontology committee, Annuaire de l'industrie member directory, Observatoire des métiers branch observatory (co-governed with CPNEIS and six trade unions), Leem Bourse de l'emploi (the #1 pharma industry job board, hosting 1,488 active postings), Pharmacopédie educational mobile app, and a Besignal-powered whistleblowing line. Proprietary frameworks include the CQP (Certificats de Qualification Professionnelle) certification system covering production, maintenance, logistics, sales, and assistant roles, plus a recurring publication library (Bilan Économique, Baromètre 360°, Santé 2030, Odoxa Observatoire sociétal).

Revenue is generated through membership dues (cotisations des adhérents) from pharmaceutical companies, fees and evaluator services for the CQP certification program, and commercialization of industry studies, barometers, and reports produced with consulting partners including Roland Berger, PwC, Ipsos, Odoxa, Simon Kucher, AEC Partners, Quantis, and Accenture. Distribution is direct via in-person events (Rencontres économiques Aix-en-Provence, Rencontres Leem/OIF Geneva, Colloque du Codeem), digital content, social channels (LinkedIn, X, Instagram, Facebook, YouTube, Dailymotion), email/newsletter, and webinars. Pricing for services, certifications, and publications is quote-based and not publicly disclosed, consistent with a non-profit professional association model.

Name

Leem

Legal name

Les Entreprises du Médicament – Leem

Website

https://leem.org

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

101–250 employees

Short description

Leem (Les Entreprises du Médicament) is the French professional trade organization representing pharmaceutical companies operating in France. It provides regulatory advocacy, ethics oversight via Codeem, CQP industry certifications, sectoral economic studies, and the leading pharma job board to its member companies and broader healthcare stakeholders.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Trade Association

NAICS

All Other Professional, Scientific, and Technical Services (54199)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Public Health Contracts, Procurement & Vendor Management (HLAJALAE)

Keywords

• Pharmaceutical industry representation
• Trade association services
• Professional certification programs
• Pharmaceutical market research
• Industry advocacy services

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership dues (cotisations des adhérents): Leem is a professional trade organization (syndicat professionnel, RCS 784 668 543) funded primarily by membership dues paid by pharmaceutical companies operating in France.
2. CQP certification fees and evaluator services: Revenue from the CQP professional qualification program (jury, evaluator network, certified training organizations) and related services to member companies.
3. Publications, studies, and reports (commercialization of industry intelligence): Production and distribution of paid/commercialized industry studies, barometers, and economic reports (Bilan Économique, Baromètre attractivité, Bilan RSE PACTES, Baromètre sociétal Odoxa).

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

Leem (Les Entreprises du Médicament) is a French professional trade association (syndicat professionnel) that represents pharmaceutical companies operating in France. It delivers industry representation, regulatory and public-affairs advocacy, ethics oversight via Codeem, industry studies and economic intelligence, a branch-recognized CQP professional qualification framework, the Bourse de l'emploi job board, the Pharmacopédie educational app, and the Prix Paroles et Talents de Patients award program.

Product overview

Leem (Les Entreprises du Médicament) is a French professional trade organization representing pharmaceutical companies operating in France, delivered through a platform-plus-modules architecture centered on leem.org. The core platform hosts industry information, news, publications, studies, policy positions and event listings, and connects to a set of named modules and services: the Espace Adhérents member portal, Le Codeem ethics and deontology committee, Le Lab dedicated section, the Bourse de l'emploi pharma job board at emploi.leem.org, the Pharmacopédie educational application, the Ligne d'alerte professionnelle whistleblowing line (hosted on besignal.com), the Annuaire de l'industrie member directory, the Observatoire des métiers branch observatory, the CQP (Certificats de Qualification Professionnelle) certification framework, the Fondation des Entreprises du Médicament foundation, and recurring awards programs such as the Prix Paroles et Talents de Patients and the Trophées PACTES.

Differentiator

Problem solved

Functional benefit

Products and services

• CQP (Certificats de Qualification Professionnelle) Branch-level professional qualification certifications for the French pharmaceutical industry, covering production (e.g., Conducteur de ligne de conditionnement), maintenance, logistics, sales (D\u00e9l\u00e9gu\u00e9 pharmaceutique) and administrative roles, awarded through a parity jury system, certified evaluator network and dedicated jury calendar.
• Leem Bourse de l'emploi Job board for the French pharmaceutical industry hosted at emploi.leem.org, hosting 1,488 active offers at time of crawl, providing employment opportunities across pharmaceutical companies and supporting talent matching for the sector.
• Pharmacop\u00e9die Educational mobile application designed to help users understand what happens to a medicine inside the human body, used for training and awareness purposes among healthcare professionals, students and the general public.
• Ligne d'alerte professionnelle Professional whistleblowing line operated on behalf of Leem via the Besignal platform, allowing industry professionals and stakeholders to report ethical concerns related to pharmaceutical companies operating in France.
• Espace Adh\u00e9rents Members-only portal for pharmaceutical companies that are Leem adherents, providing access to member-specific resources, services, the industry directory (annuaire des entreprises adh\u00e9rentes), and dedicated member tools.

Quantifiable outcome

• 110,064 LinkedIn followers on @LeemFrance
• +3 more outcomes

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

19 partnerships are on record, tiered flagship, core and minor.

• DoctolibflagshipGTM or Marketing PartnerDoctolib, in partnership with Leem and with the support of F.crin, launched a campaign to understand clinical research and inform the public about it.
• F.crincoreStrategic or Co-development PartnerF.crin (French Clinical Research Infrastructure Network) supports the Doctolib + Leem joint campaign to inform the public about clinical research.
• Organisation internationale de la Francophonie (OIF)flagshipStrategic or Co-development PartnerLong-running Rencontres Leem/OIF in Geneva; 26th edition in 2024 ('Des approches innovantes au service de la santé') and 27th edition 18 May 2025 ('Pas de santé sans talents'). Annual francophone healthcare policy dialogue.
• Roland BergercoreImplementation/ SI/ Consulting PartnerRoland Berger produces the Baromètre de l'attractivité de la France for Leem (2024 synthesis published June 2024).
• PwCcoreImplementation/ SI/ Consulting PartnerPwC produced the Baromètre 360° sur l'attractivité de la France pour l'industrie pharmaceutique (2025) and the 2023 fiscal study of the drug sector in France/Europe for Leem.
• IpsoscoreImplementation/ SI/ Consulting PartnerIpsos conducts the Observatoire sociétal (formerly reputation survey) for Leem, including the 2020, 2021, 2023 editions and a 2021 focus Jeunes.
• OdoxacoreImplementation/ SI/ Consulting PartnerOdoxa produces the Observatoire sociétal du médicament for Leem (October 2025, 2024, 2022 editions and a 2024 study on elderly patients and medicines).
• Simon KuchercoreImplementation/ SI/ Consulting PartnerSimon Kucher produced the 'Analyse de l'environnement économique des médicaments essentiels' report for Leem (April 2024).
• AEC PartnerscoreImplementation/ SI/ Consulting PartnerAEC Partners conducted the 2020 studies on AI in healthcare industries and on multi-technological solutions (SMT), and the 2020 bioproduction filière study for Leem.
• QuantiscoreImplementation/ SI/ Consulting PartnerQuantis produced the carbon footprint study of French pharmaceutical companies (2025, 2.71 Mo and 11.18 Mo editions on decarbonation roadmap).
• AccentureminorImplementation/ SI/ Consulting PartnerAccenture produced the 'Industrialisation des solutions de santé portées ou soutenues par les entreprises du médicament' study (January 2023) for Leem.
• OPCO2icoreImplementation/ SI/ Consulting PartnerOPCO2i partners with Leem on employment data and Tableau de l'emploi (Données 2024, 6.78 Mo) and on the 2024 study of medical promotion/information professions.
• OnisepcoreGTM or Marketing PartnerJoint 'Zoom sur les métiers de l'industrie du médicament' brochure (October 2024) to communicate pharmaceutical careers to students and orientation actors.
• CPNEIS (Commission Paritaire Nationale des Industries de Santé)flagshipStrategic or Co-development PartnerParity body co-governing branch actions: foresight on employment and skills, Observatory of métiers, CQP governance since 1994.
• vfa (Verband Forschender Arzneimittelhersteller)minorStrategic or Co-development PartnerJoint Leem-vfa position on European cooperation on Health Technology Assessment (HTA).
• EFPIAcoreOthersLeem adheres to EFPIA Code; ethical and deontological alignment with European pharmaceutical industry federation.
• IFPMA (FIIM)coreOthersLeem adheres to IFPMA Code (Code FIIM) governing international pharma ethical standards.
• NETSCOUADEminorImplementation/ SI/ Consulting PartnerWeb agency credited as Concepteur - Réalisateur of the leem.org website, based at 8 Passage Brûlon, 75012 Paris.
• CertifiacoreTechnology or IntegrationOnline platform used for jury inscription and management of the CQP certification process at certifia.net.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• PhRMA (Pharmaceutical Research and Manufacturers of America): Largest national pharma trade association globally, representing US research-based biopharma companies. Comparable mandate (advocacy, code, research policy, publications) but operates in a fundamentally different pricing and political environment and at much larger scale.
• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations): Global pharma industry federation to which Leem adheres through the IFPMA Code. Operates at international level setting global ethical and policy frameworks; comparable as a higher-tier trade body but with very different geographic scope.
• EFPIA (European Federation of Pharmaceutical Industries and Associations): European-level pharma trade federation representing the industry to EU institutions. EFPIA is a hierarchical peer: Leem is a member and adheres to the EFPIA Code, but EFPIA operates one level above Leem on European policy and code-setting, making it the closest direct comparator as a trade body.

Direct peers

• Farmindustria: Italian pharma trade association representing pharmaceutical companies in Italy. Highly comparable to Leem in mandate, structure, and Southern-European pricing-dialogue context with AIFA — directly competes with Leem in cross-country benchmarking.
• vfa (Verband Forschender Arzneimittelhersteller): Germany's research-based pharma trade association. vfa is Leem's closest international counterpart in structure, mandate (industry representation, pricing dialogue, code of conduct), and activities — and even partners with Leem on joint HTA positions, making it a directly comparable national pharma association.
• ABPI (Association of the British Pharmaceutical Industry): UK pharma trade association with a similar mandate to Leem: industry representation, code of practice, policy advocacy, member services, and publications. Comparable in scale and remit, though operating in a different national regulatory environment.

Others

• Doctolib: French health-tech platform that partners with Leem and F.crin on a public-information campaign about clinical research. Not a trade body but a key adjacent ecosystem partner Leem works with on patient-facing and clinical-research initiatives, making it relevant as an OTHERS-category peer for ecosystem positioning.

Regional players

• Medicines Australia: Australian pharma trade association with a comparable advocacy, code, and member-services mandate to Leem. Useful as a regional peer for benchmarking Anglo-style pharma trade body models rather than European/Continental ones.
• OPPEN (Organisation Patronale des Entreprises Pharmaceutiques au Sénégal): Sub-Saharan Francophone pharma trade associations (loosely comparable through OIF/Leem Rencontres network) that Leem engages with on Francophone health-policy dialogue. Comparable in role to Leem but at a smaller scale and different country context.

Emerging players

• AESGP (Association of the European Self-Care Industry): European self-care/OTC pharma trade association with a narrower scope than Leem (consumer health vs full pharma), but comparable as a Europe-based industry body engaged in regulatory dialogue and codes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/leemfrance
• YouTubeyoutube.com/user/LeemFrance
• Facebookfacebook.com/lemedicamentetmoi
• LinkedInlinkedin.com/company/leem
• Instagraminstagram.com/leemfrance

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Leem